Peter S. Kim

Insider Reports History

Entity
Individual
Location
One Merck Drive, P.O. Box 100, Whitehouse Station, US
Signature
/s/ Jared Cohen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter S. Kim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entrada Therapeutics, Inc. Director Common Stock 104K $1.58M $15.19 Jun 3, 2024 Direct
Entrada Therapeutics, Inc. Director Stock Option (Right to Buy) 16K Jun 13, 2024 Direct

Insider Reports Filed by Peter S. Kim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRDA Entrada Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
TRDA Entrada Therapeutics, Inc. Jun 3, 2024 2 $72.2K 4 Jun 5, 2024 Director
TRDA Entrada Therapeutics, Inc. May 14, 2024 1 $365K 4 May 16, 2024 Director
TRDA Entrada Therapeutics, Inc. May 8, 2024 2 $63.3K 4 May 10, 2024 Director
TRDA Entrada Therapeutics, Inc. Apr 8, 2024 1 $35.3K 4 Apr 10, 2024 Director
TRDA Entrada Therapeutics, Inc. Mar 28, 2024 1 $20.8K 4 Apr 1, 2024 Director
TRDA Entrada Therapeutics, Inc. Mar 22, 2024 3 $123K 4 Mar 26, 2024 Director
TRDA Entrada Therapeutics, Inc. Mar 19, 2024 3 $35K 4 Mar 21, 2024 Director
TRDA Entrada Therapeutics, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
TRDA Entrada Therapeutics, Inc. Jun 2, 2022 1 $0 4 Jun 6, 2022 Director
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 1 $0 4 Nov 1, 2021 Director
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 Director